Breakthrough Innovative Medical Device: The Nasalis System™ addresses the risks of opioid misuse. The Nasalis System™ provides rapid, safe, easy and reliable method to accurately deliver opioid / pain medication and eliminates the risks of opioid misuse and fatal opioid overdoses.
This delivery method facilities for a faster and more direct pathway to the brain for the treatment of pain or other therapeutic purposes. As a result, less medication can be introduced to the body or lost in the delivery process.
No Current devices exist in the marketplace today which do not provide any form of aversion to misuse, thus are vulnerable to abuse. In addition, the opioid epidemic has been fueled by current devices and medical practices which are not incentivized to limit the dependence on medications. The lack of viable and sustainable methods for tracking medicinal usage with current devices has led to un-accountability and over-prescription.
As a result, patients’ prescribed pain medication management are predisposed to opioid addiction due to the lack of treatments based on patient usage analysis intended to prevent medicinal dependence.
The Nasalis System™ addresses the risks of opioid misuse by way of the company’s patent innovative medical drug delivery technology using behavioral psychology, predictive analytics as well as blockchain security to ensure patient compliance while educating them on using their own bio-feedback to accurately project an individuals pain thresholds to change behaviors before need arises.
Company’s Keywords:
prevention of opioid overdoses, invention patenting, medical device to address the opioid abuse epidemic, opioidbreakthrough, device is currently submitted for fda approval as a class 1 medical device, innovative drug delivery medical device
<1
<
<2018
Your request has been submitted successfully.
Own or work here?